Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.30
-0.30 (-1.70%)
Jan 21, 2026, 2:10 PM CET

STO:ANNX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-38.73-50.25-44.05-40.73-52.14-44.24
Upgrade
Depreciation & Amortization
0.190.190.190.190.190.19
Upgrade
Other Operating Activities
0.0400-5.194.28
Upgrade
Change in Accounts Payable
-0.08-1.371-0.180.610.49
Upgrade
Change in Other Net Operating Assets
0.851.2-0.54-0.451.130.08
Upgrade
Operating Cash Flow
-37.72-50.23-43.4-41.17-45.02-39.2
Upgrade
Capital Expenditures
-0.13-----
Upgrade
Investment in Securities
--0.1-0.26--0.1
Upgrade
Investing Cash Flow
-0.13-0.1-0.26--0.1
Upgrade
Long-Term Debt Issued
-510-204
Upgrade
Long-Term Debt Repaid
------4.23
Upgrade
Net Debt Issued (Repaid)
-510-20-0.23
Upgrade
Issuance of Common Stock
49.9740.0626.523.1166.6661.01
Upgrade
Other Financing Activities
-0.880.1-2.9-0.05-10.29-7.62
Upgrade
Financing Cash Flow
49.0945.1533.6123.0676.3753.16
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0-0---
Upgrade
Net Cash Flow
11.24-5.08-9.7-18.3731.3513.87
Upgrade
Free Cash Flow
-37.85-50.23-43.4-41.17-45.02-39.2
Upgrade
Free Cash Flow Per Share
-6.12-11.11-25.97-28.14-54.88-63.73
Upgrade
Cash Interest Paid
0.050.050--0.5
Upgrade
Levered Free Cash Flow
-23.29-31.48-26.87-26.05-28.92-23.16
Upgrade
Unlevered Free Cash Flow
-23.29-31.48-26.87-26.05-27.76-22.85
Upgrade
Change in Working Capital
0.77-0.170.46-0.631.740.57
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.